Current Stem Cell Research & Therapy

Scope & Guideline

Elevating the Science of Stem Cells for Better Health

Introduction

Explore the comprehensive scope of Current Stem Cell Research & Therapy through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Current Stem Cell Research & Therapy in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1574-888x
PublisherBENTHAM SCIENCE PUBL LTD
Support Open AccessNo
CountryUnited Arab Emirates
TypeJournal
Convergefrom 2006 to 2024
AbbreviationCURR STEM CELL RES T / Curr. Stem Cell Res. Ther.
Frequency8 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressEXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES

Aims and Scopes

Current Stem Cell Research & Therapy focuses on advancing the understanding and therapeutic applications of stem cells across various medical domains. The journal emphasizes innovative research that explores the mechanisms, efficacy, and safety of stem cell therapies, while also addressing the challenges in regenerative medicine.
  1. Stem Cell Mechanisms and Pathways:
    Research exploring the underlying biological mechanisms of stem cells, including signaling pathways, differentiation processes, and the effects of various factors on stem cell behavior.
  2. Clinical Applications of Stem Cells:
    Studies focusing on the therapeutic applications of stem cells in treating various diseases, including but not limited to neurodegenerative disorders, cardiovascular diseases, and autoimmune conditions.
  3. Stem Cell Sources and Characteristics:
    Investigations into different sources of stem cells, such as mesenchymal stem cells, induced pluripotent stem cells, and embryonic stem cells, along with their unique properties and potential therapeutic uses.
  4. Exosomes and Secretome in Stem Cell Therapy:
    Research on the role of stem cell-derived exosomes and secretome in mediating therapeutic effects, including their potential in tissue repair and regeneration.
  5. Tissue Engineering and Regenerative Medicine:
    Studies involving the integration of stem cells with biomaterials and scaffolds to enhance tissue regeneration and repair in various medical applications.
  6. Safety and Efficacy of Stem Cell Therapies:
    Meta-analyses and systematic reviews assessing the safety, efficacy, and long-term outcomes of stem cell therapies in clinical settings.
The journal has witnessed an increase in research themes that highlight innovative approaches and emerging areas of interest in stem cell therapy. This section discusses the trending scopes that are shaping the future of the field.
  1. Exosome Research and Applications:
    There is a growing trend in the exploration of exosomes derived from stem cells, focusing on their roles in intercellular communication and potential as therapeutic agents in regenerative medicine.
  2. Combination Therapies Involving Stem Cells:
    Recent publications emphasize the use of stem cells in combination with other therapeutic modalities, such as gene therapy, nanomaterials, and pharmacological agents, to enhance treatment outcomes.
  3. Technological Advances in Stem Cell Research:
    The integration of advanced technologies, such as CRISPR gene editing, bioinformatics, and 3D bioprinting, is increasingly being recognized for its potential to revolutionize stem cell applications and tissue engineering.
  4. Personalized Medicine Approaches:
    Emerging themes highlight the personalization of stem cell therapies based on patient-specific factors, including genetic and epigenetic profiles, to optimize treatment efficacy and safety.
  5. Focus on Aging and Stem Cells:
    Research addressing the implications of aging on stem cell function and the development of therapies targeting age-related diseases is gaining momentum, reflecting an increasing interest in geriatric medicine.

Declining or Waning

As the field of stem cell research evolves, certain themes have shown a decline in prominence within the journal. This section highlights these waning scopes, which may reflect shifts in research focus or challenges in clinical application.
  1. Basic Science of Stem Cells:
    While foundational research on stem cell biology remains important, there has been a noticeable decline in publications focused solely on basic science without direct clinical implications, as the field moves towards more applied research.
  2. Non-Mesenchymal Stem Cell Applications:
    Research centered on non-mesenchymal stem cells, such as hematopoietic stem cells or embryonic stem cells, has decreased, possibly due to the increased focus on mesenchymal stem cells and their therapeutic versatility.
  3. In-vitro Studies Without Clinical Relevance:
    There has been a reduction in the publication of purely in-vitro studies that do not translate into clinical applications, as the journal emphasizes studies that demonstrate clear potential for therapeutic use.
  4. Single-source Stem Cell Studies:
    Research focusing on single-source stem cells (e.g., only one type of stem cell) is less common, reflecting a shift towards comparative studies that assess multiple stem cell types and sources for broader therapeutic implications.

Similar Journals

STEM CELLS

Driving collaboration in cutting-edge biological research.
Publisher: OXFORD UNIV PRESSISSN: 1066-5099Frequency: 12 issues/year

STEM CELLS, published by Oxford University Press, is a leading academic journal dedicated to advancing the field of cell and developmental biology. With an impressive impact factor and ranking in the Q1 and Q2 quartiles across various disciplines, including Developmental Biology and Molecular Medicine, this journal serves as a critical platform for disseminating cutting-edge research findings from 1981 to the present. The journal's rigorous peer-review process ensures the highest quality of published content, making it an essential resource for researchers, healthcare professionals, and students interested in the latest breakthroughs in stem cell research and its applications. With a focus on innovative methodologies and holistic perspectives, STEM CELLS not only highlights significant discoveries but also fosters a collaborative exchange of ideas, driving forward the frontiers of science in regenerative medicine and developmental studies.

CELL AND TISSUE RESEARCH

Advancing the Frontiers of Cell Biology and Tissue Dynamics
Publisher: SPRINGERISSN: 0302-766XFrequency: 12 issues/year

CELL AND TISSUE RESEARCH, published by Springer, is a premier journal dedicated to advancing the field of cell biology, histology, pathology, and forensic medicine. With a proud history dating back to its foundation in 1924 and continuing its legacy, this journal has established itself as a vital source for innovative research, facilitating the dissemination of significant findings that contribute to the understanding of cellular and tissue dynamics. Hailing from Germany, the journal exhibits an impressive standing in the academic community with a 2023 impact factor reflected in its category quartiles: Q2 in Cell Biology, Q1 in Histology, and Q1 in Pathology and Forensic Medicine. It ranks notably within multiple Scopus categories, including 32/208 in Pathology and Forensic Medicine and 13/62 in Histology, showcasing its high percentile rankings of 84th and 79th, respectively. Researchers, professionals, and students benefit from its extensive coverage and rigorous peer-review process that ensures the integrity and relevance of its published works, thus making it an essential resource in the scientific community. While it operates under a subscription model, its commitment to quality and impact makes it an indispensable journal for anyone engaged in cellular and tissue research.

Inflammation and Regeneration

Empowering discoveries in inflammation and regenerative therapies.
Publisher: BMCISSN: Frequency: 1 issue/year

Inflammation and Regeneration is a prominent open-access journal published by BMC, focused on the discerning fields of immunology, cell biology, and regenerative medicine. Since its establishment in 2016, the journal has provided a platform for the dissemination of high-quality research, contributing significantly to the advancement of knowledge in inflammation processes and regenerative therapies. With a remarkable impact reflected in its Q1 quartile rankings in Cell Biology and Immunology for 2023, Inflammation and Regeneration stands out as a leading resource for researchers and practitioners. The journal's commitment to open access ensures that critical findings are readily available to a global audience, fostering collaboration and innovation in the scientific community. With a Scopus ranking that places it in the top 20% of its categories, Inflammation and Regeneration serves as an essential reference for those seeking to stay at the forefront of immunological research and its applications.

Regenerative Engineering and Translational Medicine

Transforming Research into Real-World Solutions
Publisher: SPRINGER HEIDELBERGISSN: 2364-4133Frequency: 4 issues/year

Regenerative Engineering and Translational Medicine is an esteemed academic journal published by Springer Heidelberg, focusing on the interdisciplinary fields of biomaterials, biomedical engineering, and cell biology. With an ISSN of 2364-4133 and an E-ISSN of 2364-4141, the journal has carved a niche for itself since its inception in 2015, showcasing cutting-edge research that bridges the gap between scientific findings and practical applications in regenerative medicine. As a recognized platform in its field, it is currently positioned within Q3 quartiles in biomaterials, biomedical engineering, and medicine (miscellaneous), with a Scopus ranking that reflects its growing influence among peers. The journal aims to disseminate high-quality, peer-reviewed articles that highlight advancements in regenerative engineering, further advancing both theoretical and applied research. Scholars and practitioners seeking to stay at the forefront of the ever-evolving landscape of regenerative health solutions will find invaluable insights and innovations within these pages. Join a community of leading thinkers and explore the journal's comprehensive research contributions, which are crucial for fostering partnerships between academia and industry in the quest for transformative medical solutions.

NEUROCHEMISTRY INTERNATIONAL

Fueling Scientific Collaboration in Neurobiological Innovations
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 0197-0186Frequency: 10 issues/year

NEUROCHEMISTRY INTERNATIONAL, published by Pergamon-Elsevier Science Ltd, offers a premier platform for researchers and professionals in the realms of cell biology and cellular and molecular neuroscience. Established in 1980 and continuing its passion for advancing the field, this esteemed journal enhances scientific collaboration with a notable 2023 Q2 ranking in both relevant categories, placing it among the top-tier publications in its discipline with a Scopus rank of 23/97 for Cellular and Molecular Neuroscience. With its focus on groundbreaking research, the journal provides a wealth of vital data and insights that drive forward our understanding of neurochemistry and its implications in health and disease. While not an Open Access journal, NEUROCHEMISTRY INTERNATIONAL is integral for professionals, academics, and students aiming to stay at the forefront of neurobiological research innovations, making significant contributions to both academia and clinical applications.

DIFFERENTIATION

Unveiling the Secrets of Biological Differentiation
Publisher: ELSEVIER SCI LTDISSN: 0301-4681Frequency: 6 issues/year

DIFFERENTIATION is a respected peer-reviewed journal published by Elsevier Science Ltd, dedicated to advancing knowledge in the fields of Cancer Research, Cell Biology, Developmental Biology, and Molecular Biology. With an established history since 1973, the journal continuously explores the intricacies of cellular and molecular processes that govern differentiation in biological systems, thus playing a pivotal role in shaping contemporary research directions. Currently indexed in the Q3 quartile across multiple relevant categories, it provides a crucial platform for researchers to disseminate their findings and engage with the scientific community. DIFFERENTIATION does not offer open access, but it remains a valuable resource for academics seeking to enhance their understanding of the fundamental mechanisms that underpin life sciences. By fostering a rigorous dialogue among scientists, it contributes significantly to the ever-evolving landscape of biochemistry and genetics.

CYTOTECHNOLOGY

Cultivating Discovery: Inspiring New Horizons in Bioengineering and Biotechnology.
Publisher: SPRINGERISSN: 0920-9069Frequency: 6 issues/year

CYTOTECHNOLOGY, an esteemed journal published by Springer, stands as a vital resource in the fields of Bioengineering, Biomedical Engineering, and Biotechnology. With an impact factor reflective of its solid position within academia, this journal encompasses a broad scope dedicated to the advancement of cytotechnological research and applications from its inception in 1987 through to its latest volumes in 2024. Based in the Netherlands, it is committed to providing researchers, professionals, and students with high-quality, peer-reviewed articles that contribute to the understanding and innovations in cytotechnology. Although currently not open access, CYTOTECHNOLOGY has garnered a commendable reputation, holding Q3 rankings in multiple categories, indicating its relevance and influence within the scientific community. Researchers are encouraged to submit their cutting-edge findings to share insights that can spark further advancements in this dynamic field.

Regenerative Therapy

Exploring the future of biomaterials and biomedical engineering.
Publisher: ELSEVIERISSN: 2352-3204Frequency:

Regenerative Therapy is a premier open-access journal dedicated to advancing the fields of biomaterials, biomedical engineering, and developmental biology. Published by Elsevier in Japan, this journal has been an influential platform since its inception in 2015, contributing significantly to the global discourse on regenerative medicine. With an impressive Q2 ranking in major categories such as Biomaterials and Biomedical Engineering, it is recognized for its quality of research and innovation. Researchers seeking to disseminate their findings or explore cutting-edge developments will find Regenerative Therapy to be invaluable, reflecting current trends and fostering collaborations across interdisciplinary boundaries. The journal offers open access, ensuring that high-quality research is available to a broad audience and enhances the impact of scholarly work in the regenerative medicine community.

Stem Cell Research & Therapy

Catalyzing Discoveries in Molecular Medicine
Publisher: BMCISSN: Frequency: 1 issue/year

Stem Cell Research & Therapy is an esteemed international journal published by BMC, specializing in the rapidly advancing fields of stem cell research and regenerative therapies. Since its inception in 2010, the journal has embraced an Open Access model, ensuring that vital research is readily accessible to a global audience. With a significant impact in the scientific community, it holds Q1 quartile rankings in prestigious categories such as Biochemistry, Genetics and Molecular Biology, Cell Biology, and Molecular Medicine, highlighting its critical role in promoting groundbreaking research. The journal’s high Scopus rankings—placing it in the top echelons of its fields—reflect its commitment to publishing high-quality, peer-reviewed studies that advance our understanding of stem cell biology and therapeutic applications. Aimed at researchers, healthcare professionals, and students alike, Stem Cell Research & Therapy is an indispensable resource for those dedicated to the exploration and innovation within this transformative area of science.

Stem Cell Reviews and Reports

Fostering Collaboration in Cutting-edge Research
Publisher: SPRINGERISSN: 2629-3269Frequency: 8 issues/year

Stem Cell Reviews and Reports is a prestigious journal published by SPRINGER specializing in the dynamic field of stem cell research, encompassing various aspects of cell biology and cancer research. With an ISSN of 2629-3269 and E-ISSN of 2629-3277, this journal serves as an essential resource for academics, offering insightful reviews and cutting-edge reports from 2009 to 2024. The journal has achieved a commendable Q2 ranking in both Cancer Research and Cell Biology categories as of 2023, highlighting its significant contribution to the scientific community. Additionally, with Scopus rankings placing it in the 74th percentile for both biochemistry and cell biology, it is recognized for its high-quality articles that foster innovative approaches in stem cell therapy and regenerative medicine. As an Open Access publication, Stem Cell Reviews and Reports ensures that its comprehensive content is readily available to researchers, professionals, and students, promoting collaboration and advancement in this vital area of study.